These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29161904)

  • 1. Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice.
    Leicher LW; Lammertink MHA; Offerman SR; Morreau H; de Jong MM; de Groot JWB; van Westreenen HL; Vasen HFA; de Vos Tot Nederveen Cappel WH
    Scand J Gastroenterol; 2018 May; 53(5):632-636. PubMed ID: 29161904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
    Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
    Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
    Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
    Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer due to deficiency in DNA mismatch repair function: a review.
    Bellizzi AM; Frankel WL
    Adv Anat Pathol; 2009 Nov; 16(6):405-17. PubMed ID: 19851131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer.
    Sandoval RL; Horiguchi M; Ukaegbu C; Furniss CS; Uno H; Syngal S; Yurgelun MB
    Fam Cancer; 2023 Oct; 22(4):459-465. PubMed ID: 37572151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability testing and its role in the management of colorectal cancer.
    Kawakami H; Zaanan A; Sinicrope FA
    Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome.
    Poulogiannis G; Frayling IM; Arends MJ
    Histopathology; 2010 Jan; 56(2):167-79. PubMed ID: 20102395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
    Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
    Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
    Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
    J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
    Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch repair protein status of non-neoplastic uterine and intestinal mucosa in patients with Lynch syndrome and double somatic mismatch repair protein mutations.
    Freitag CE; Chen W; Pearlman R; Hampel H; Stanich PP; Cosgrove CM; Konnick EQ; Pritchard CC; Frankel WL
    Hum Pathol; 2023 Jul; 137():1-9. PubMed ID: 37030500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
    Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
    Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
    van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
    J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis.
    Haraldsdottir S; Roth R; Pearlman R; Hampel H; Arnold CA; Frankel WL
    Fam Cancer; 2016 Apr; 15(2):253-60. PubMed ID: 26666765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression.
    Sorscher S
    Breast Cancer Res Treat; 2019 Nov; 178(2):469-471. PubMed ID: 31392519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
    Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
    Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with mismatch repair testing in pT1 colorectal cancer diagnosed before the age of 70 years.
    Ykema BLM; Nagtegaal ID; Kuhlmann K; van Berkel AM; van Leerdam ME;
    Virchows Arch; 2021 Sep; 479(3):451-457. PubMed ID: 33718978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer.
    Li Y; Fan L; Zheng J; Nie X; Sun Y; Feng Q; Lian S; Bai W; Cai W; Yang Y; Su B; Xi Y; Lin D
    Cancer Biol Med; 2022 Jun; 19(8):1235-48. PubMed ID: 35638907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.